For example, the characteristics of LMP1 in predicting prognosis of lymphoma from these 15 studies were contradictory, i.e., three studies reported LMP1 as a predictor of favorable prognosis, whereas six studies suggested LMP1 protein as the poor prognosis indicator, but the remaining six studies showed no significant impact of LMP1 expression on overall survival of lymphoma patients. This evidence concerns the gene PDLIM7 and lymphoma.